Committee votes and key actions: what advanced, what was tabled

The Maine Legislature's Committee on Health Coverage, Insurance and Financial Services advanced several bills during its Jan. 21 session and tabled or left others without final recommendations.

Among the measures the committee approved in work session: LD2060, a Department of Professional and Financial Regulation bill that makes technical corrections to the Maine Uniform Securities Act, received a unanimous committee work-session endorsement and an "ought to pass" recommendation. Jesse Devine, the Maine securities administrator, told the committee the bill corrects a federal citation, replaces one instance of "registration" with "licensure" and clarifies the administrator's ability to grant licensing exemptions for broker-dealer firms.

LD1502, which updates requirements for insurance coverage of prostate cancer screening by tying age and frequency standards to nationally recognized clinical practice guidelines and eliminating certain cost-sharing provisions in line with the sponsor's amendment, passed in work session (10 affirmative, 1 negative).

LD2072, a Bureau of Financial Institutions department bill that among other changes would allow state-chartered credit unions to make loans secured by out-of-state real estate and repeal statutory volume fees, passed as amended (9-0).

Bills the committee left for further work: LD2061 (clarification of the ban on fees for paper billing statements) was tabled to allow the sponsor and the Bureau of Financial Institutions to draft clarifying language about "periodic" statements and fee disclosure; LD1803 (optometry scope of practice) was tabled after extensive debate about training, credentialing and patient safety; LD1901 (shared appreciation agreements, a newer home-equity product) was tabled after industry and consumer advocates debated whether the products are credit or investment instruments; and LD519 (the Magura reinsurance program) remains under study after bureau officials presented actuarial options for stabilizing funding.

The committee also debated LD1530 (changes to ambulance and non-transport emergency medical service reimbursement). The assembly considered a motion "ought not to pass," which received five affirmative votes and six negative votes, so no final committee recommendation was adopted and the work session closed with the issue unresolved.

Next steps: Tabled bills were generally left with instructions for sponsors and relevant state bureaus to draft clarifying amendments or return with additional analysis; the committee asked for follow-up reports and, in several cases, additional stakeholder negotiation before another vote.

Votes at a glance (work-session outcomes captured in committee): - LD2060 (Uniform Securities Act technical fixes): Ought to pass (10-0). - LD1502 (prostate screening coverage, as amended): Ought to pass as amended (10-1). - LD2072 (Bureau of Financial Institutions departmental bill): Ought to pass as amended (9-0). - LD2061 (paper billing clarification): Tabled for sponsor/bureau amendment. - LD1803 (optometry scope of practice): Tabled for further stakeholder work. - LD1901 (shared appreciation agreements): Tabled for further analysis and draft language. - LD519 (Magura reinsurance funding): Tabled; bureau to provide further modeling and options. - LD1530 (EMS/ambulance reimbursement): No final committee recommendation after a failed motion to adopt "ought not to pass" (5-6 vote).

The committee indicated it will reconvene work sessions as sponsors and agencies return with amended language or additional data.